Compare Indivior Pharmaceuticals Inc. Common Stock (INDV) vs Northern Trust Corporation Common Stock (NTRS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Indivior Pharmaceuticals Inc. Common Stock vs Northern Trust Corporation Common Stock — how do they compare? Indivior Pharmaceuticals Inc. Common Stock trades at $34.01 (market cap $4.18B), while Northern Trust Corporation Common Stock trades at $162.48 (market cap $30.63B). The key difference: Northern Trust Corporation Common Stock is far larger — about 7.3× Indivior Pharmaceuticals Inc. Common Stock's market cap, and Northern Trust Corporation Common Stock pays a 1.96% dividend while Indivior Pharmaceuticals Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Indivior Pharmaceuticals Inc. Common Stock for 0 Days and Northern Trust Corporation Common Stock for 0 Days on average.
| INDV | NTRS | |
|---|---|---|
Market Cap | $4.18B | $30.63B |
Volume | 1,819,746 | 964,550 |
Sector | Health | Financials |
52-Week High | $41.83 | $191.47 |
52-Week Low | $24.09 | $122.72 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $4.47B | -$5.35B |
Dividend Yield | — | 1.96% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Indivior Pharmaceuticals Inc. Common Stock
Indivior Pharmaceuticals, Inc. is a pharmaceutical company focused on treatments for opioid use disorder and other addiction-related conditions, including its Suboxone film and tablet products.
Read more on INDV →About Northern Trust Corporation Common Stock
Northern Trust Corporation is a financial holding company that provides asset servicing, asset management, wealth management, and banking services through its Asset Servicing and Wealth Management segments. It serves corporations, institutions, and affluent individuals across US and international markets.
Read more on NTRS →
